Novavax says it could start making Omicron-specific vaccine in January
Go back to Novavax says it could start making Omicron-specific vaccine in January| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 12.56 +2.10 (20.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.46 | 52 Week High | $9.23 | |||
| Open | $10.47 | 52 Week Low | $1.16 | |||
| Day High | $13.39 | P/E | N/A | |||
| Day Low | $10.28 | EPS | $-0.30 | |||
| Volume | 28,673,354 | |||||



